UBS Starts Ultragenyx Pharma (RARE) at Neutral
UBS initiates coverage on Ultragenyx Pharma (NASDAQ: RARE) with a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

